Original document(7 pages)  中文版
    The present invention offers a prepn. process of medicines for the treatment of tumors. The medicines are mainly made of Chinese herbs, in which Pulvis Crotonis Tiglium and camphor are dominant, and Borneolum etc as subsidiary, the form of admin. is external application. It has a rapid therapeutic efficiency upon cellular hyperplastic diseases, such as benign tumors, malignant tumors and verruca vulgaris etc.
Application Number
申请号		 88104055 Application Date
申请日		 1988.06.28
Title 名称 Compounding process of fast-acting tumour-dispelling ointment (No.1 and No.2)
Publication Number
公开号		 1038937 Publication Date
公开日		 1990.01.24
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K35/78
Applicant(s) Name
申请人		 Xu Zhiwu
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
High efficiency aluminium base composite material liquid phase vibrating welding method
Medicine for eliminating tumor
Electric-arc blowing-force controlled pulse protective gas TIG or MIG welding gun
Aluminium base composite material ultrasonic wave fine welding method
Non preheating argon arc fusion welding method for thick red copper plate
Aluminium base composite material ultra sonic electrical resistance welding method
Composite welding wire for welding red copper thick plate without preheating and its welding method
Filling composite welding flux vibrating liquid phase welding method for non-continuous strengthening aluminium base composite material
Aluminum, aluminum alloy and composite material ultrasonic vibration liquid phase welding equipment therefor
AC tungsten inert gases welding electric arc micro-melting brazing procedure for aluminium, titanium and diverse metal alloy thereof
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.